Last update Dec. 8, 2017
Compatible
We do not have alternatives for N,N-Diethyl-3-methylbenzamide since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
N,N-Diethyl-3-methylbenzamide is also known as Diethyltoluamide.
N,N-Diethyl-3-methylbenzamide in other languages or writings:
N,N-Diethyl-3-methylbenzamide belongs to this group or family:
Main tradenames from several countries containing N,N-Diethyl-3-methylbenzamide in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | Dermat. 9 - 56 ; Oral 100 | % |
Molecular weight | 191 | daltons |
Tmax | 1 - 2 | hours |
T½ | 2.5 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by IHAN of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Diethyltoluamide or DEET is an effective insect repellent against mosquitoes, black flies, ticks and fleas.
Since the last update, we have not found published data on its excretion in breast milk.
Its pharmacokinetic data (low molecular weight, moderate cutaneous absorption and highly lipophilic) make its transfer to milk possible in amounts that could be significant.
There is no evidence that the use of DEET in breastfeeding mothers affects the child (Koren 2003).
Avoid the use of products with a concentration higher than 25%, do not use over extended areas of skin (Chen 2009) and do not apply to the chest. Avoid contact with the baby and ventilate well.
It is a product which is approved by the American Academy of Pediatrics for use in infants older than two months at concentrations not exceeding 30% (AAP 2017).
WHO list of essential medicines: compatible with breastfeeding (WHO / UNICEF, 2002).